z-logo
open-access-imgOpen Access
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
Author(s) -
Silvia Scoccianti,
Emanuela Olmetto,
Valentina Pinzi,
Mattia Falchetto Osti,
Rossella Di Franco,
Saverio Caini,
Paola Anselmo,
Paolo Matteucci,
Davide Franceschini,
Cristina Mantovani,
G. Beltramo,
Francesco Pasqualetti,
Alessio Bruni,
Paolo Tini,
Emilia Giudice,
Patrizia Ciammella,
Anna Merlotti,
Sara Pedretti,
M. Trignani,
Marco Krengli,
Niccolò Giaj-Levra,
Isacco Desideri,
Guido Pecchioli,
Paolo Muto,
Ernesto Maranzano,
Laura Fariselli,
Pierivarria,
Umberto Ricardi,
Vieri Scotti,
Lorenzo Livi
Publication year - 2021
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noab129
Subject(s) - medicine , stereotactic radiotherapy , radiosurgery , lung cancer , toxicity , retrospective cohort study , radiation therapy , oncology , immunotherapy , adenocarcinoma , cancer , surgery
To define efficacy and toxicity of Immunotherapy (IT) with stereotactic radiotherapy (SRT) including radiosurgery (RS) or hypofractionated SRT (HFSRT) for brain metastases (BM) from non-small cell lung cancer (NSCLC) in a multicentric retrospective study from AIRO (Italian Association of Radiotherapy and Clinical Oncology).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom